The nonalcoholic fatty liver disease (NAFLD) fibrosis score, cardiovascular risk stratification and a strategy for secondary prevention with ezetimibe

The nonalcoholic fatty liver disease fibrosis score (NFS) is comprised of unique metabolic risk indicators that may accurately predict residual cardiovascular (CV) risk in patients with established coronary disease and metabolic dysfunction.

Source: International Journal of Cardiology - May 26, 2018 Category: Cardiology Authors: Tracey G. Simon, Kathleen E. Corey, Christopher P. Cannon, Michael Blazing, Jeong-Gun Park, Michelle L. O'Donoghue, Raymond T. Chung, Robert P. Giugliano Source Type: research